Objectives: To determine the relevance of Mini-Mental State Examination (MMSE), serum 25-hydroxyvitamin D (25(OH)D3), and 1,25(OH)2D3 concentrations to mild cognitive impairment (MCI) and various stages of Alzheimer's disease (AD).
| INTRODUCTION
Alzheimer's disease (AD) is the most common cause of cognition impairment in elderly populations. AD is characterized by dementia with progressive loss of memory, intellectuality, disturbance of language ability, impairment in social performance, and reduced independence (i.e., the need for caregiver support in daily life). Although a definitive diagnosis of AD can only be made based on histopathological examination of brain specimens, the clinical diagnosis of AD could have a high degree of accuracy if dementia is diagnosed using a cognitive score (Creavin et al., 2016; Votruba, Persad, & Giordani, 2016) . In addition to age and gender, the Mini-Mental State Examination (MMSE) has been regarded as a useful instrument for evaluating the cognitive state of patients (Folstein, Folstein, & McHugh, 1975) and used as a predictor of AD (Musicco et al., 2009 ). Mild cognitive impairment (MCI) is subclinical complaint of memory function in elderly people. It has been reported that 10%-20% of individuals over the age of 65 years suffer from MCI (Petersen, 2011) , with high potential of converting to AD (Devanand et al.,2008; Ganguli et al., 2011; Petersen et al., 2001; Ritchie & Touchon, 2000) .
In addition to its known significance in bone and calcium homeostasis, vitamin D improves protein homeostasis and slows aging (Mark et al., 2016) . The enzymes involved in conversion of 25(OH)D 3 to 1,25(OH) 2 D 3 are all present in the brain (Harms, Burne, Eyles, & McGrath, 2011) . There is a reciprocal relationship between vitamin D and AD. It has been reported that 25(OH)D 3 is reduced in late-onset AD, and vitamin D deficiency is regarded as a risk factor for ApoEε4 noncarrier patients with AD (Dursun et al., 2016) . On the other hand, supplementation with vitamin D derivatives decreases the risk of AD (Dean, Bellgrove, & Hall, 2011) . It has recently been found that vitamin D receptors are colocalized with amyloid precursor protein on the neuronal plasma membrane (Dursun & Gezen-Ak, 2017) . Amyloid β (Aβ), the pathological hallmark of AD, degrades vitamin D receptor (Dursun, Gezen-Ak, & Yilmazer, 2010) . Vitamin D decreases the burden of major pathological aggregates in AD, including Aβ plaques and hyperphosphorylated tau protein (Durk, Han, & Chow, 2014; Yu et al., 2011) and augments activity of memantine in AD (Lemire, Brangier, Beaudenon, Duval, & Annweiler, 2016) . Moreover, many reports suggest a relationship between vitamin D deficiency with MCI (Annweiler et al., 2012; Yin, Fan, Lin, Xu, & Zhang, 2015) and AD (Annweiler et al., 2010 (Annweiler et al., , 2011 Landel, Annweiler, Millet, Morello, & Féron, 2016; Nissou et al., 2014; Schlögl & Holick, 2014) .
There are several measures that could distinguish AD from control subjects. These include decreased metabolism of fluorodeoxyglucose (Silverman et al., 2001) , increased uptake of amyloid (Small et al., 2006) , elevated levels of tau or its phosphorylated form, and decreased amyloid β42 in CSF (Hansson et al., 2006; Querfurth & LaFerla, 2010; Sunderland et al., 2003) . However, these approaches are either invasive or very expensive. Therefore, there is still a need for developing diagnosis as well as treatment approaches to diseases characterized by dementia. Also, as to our knowledge, no study of possible use of both 25(OH)D 3 and 1,25(OH) 2 D 3 , separately or in combination with MMSE, as predictors in diagnosis and prediction of MCI and various stages (mild, moderate, and severe) of AD. Accordingly, this study was conducted to evaluate utility of MMSE, serum 25(OH) D 3, and 1,25(OH) 2 D 3 concentrations in prediction and diagnosis patients with MCI and the various stages of AD.
| MATERIALS AND METHODS

| Participants
A total of 230 individuals from Fukuoka University Hospital were included in this study. The participants were allocated to three groups: I-Healthy subjects (HS), II-patients with MCI and III-patients with AD main group classified, according to disease severity, into three stages defined as 1-mild AD, 2-moderate AD, and 3-severe AD. Diagnosis of MCI was performed according to Petersen's criteria (Petersen, 2011; Petersen et al., 2001; Ritchie & Touchon, 2000) . The severity of cognitive impairment in patients with AD was evaluated using MMSE scores: mild AD (27 ≥ MMSE > 20), moderate AD (20 ≥ MMSE > 10), and severe AD (10 > MMSE) (Feldman, Van Baelen, Kavanagh, & Torfs, 2005; O'Bryant, Humphreys, & Smith, 2008) . Each participant was clinically evaluated by set of tests that included questionnaire and a proxy interview, assessment of past and present illness, neurological and physical examinations, blood chemistry, and neuroimaging with computed tomography and/or magnetic resonance imaging. Some participants in the HS group had hypertension (eight of 33; 24%) and/ or hypercholesterolemia (four of 33; 12%), regarded above the baseline blood pressure (systolic 139/diastolic 89 mmHg) and cholesterol (219 mg/dl). All groups were gender-balanced except there were two times as many women as men in the moderate and severe AD groups.
Moreover, the groups were also age-matched except the difference between women moderate AD compared to women HS (p = .23) and men HS (p = .013). The respective ages (year) of women and men were as follows: HS (74.5 ± 6.3; 74.4 ± 8.7) , MCI (75.5 ± 6.8, 77.7 ± 11.2), mild AD (74.8 ± 8.1; 78.3 ± 6. 3), moderate AD (82.2 ± 5.1; 76.9 ± 7.6), and severe AD (77.7 ± 8.7; 76.5 ± 9.1). A difference was detected only between moderate AD women and HS women (p = 0.031), and between moderate AD women and moderate AD men (p = 0.016).
This difference is consequent to grouping according to the clinical classification to MCI or AD. All participants were free of hepatic and renal disorders. The ethical permission for this study was obtained from the ethical committee of Fukuoka University Hospital. The study was performed in accordance with the ethical standards of the 1964 Helsinki Declaration. Written informed consent was obtained from all participants or their relatives prior to their participation in the study.
We excluded participants with any present or earlier history of vitamin D supplementation.
| Samples preparations and analyses
Peripheral blood was collected from each participant and centrifuged at 400 x g for 20 min. The sera obtained were stored at .
The predictors were also tested with univariate logistic regression analyses to assess the contribution of each predictor alone to each group. Then, multivariate-forward selection analyses were conducted to assess the contribution of the predictors in combination to increase the statistical power and account for the individual differences in prediction. Variables which had a p value of >.05 were excluded.
The followings were calculated: β: logistic regression coefficient describes the size and direction of the relationship between a predictor and the disease (predictive value). Positive predictive value is the probability that a subject classified as a patient by the test belongs in the patient group becomes more likely as the predictor increases.
Negative predictive value is the probability that a subject classified as a nonpatient by the test belongs in the nonpatient group. It also indicates the inverse relationship between the predictor and the disease (decreased predictor means increased disease odd). Odd ratio (OR):
the ratio of the odds, calculated as the exponent of β. OR is the measurement of likelihood and indicates that when the predictor is raised by one unit the odds ratio of the outcome increase by a factor equal to the OR value, that is, the odds of participants in the dependent variable (patients) increase by a factor equivalent to OR value with 95% confidence interval (CI). Correct classification, CC (accuracy rate (%) of the predictor to diagnose or distinguish two compared variables), and Wald value (significance of predictor contribution) were also measured.
Receiver operating characteristic (ROC) analysis provides useful information regarding the ability of a predictor to classify subjects into the relevant groups, and to compare the performance of more than one predictor. ROC was conducted to calculate area under the ROC curve (AUC), sensitivity, and specificity. Cutoff values at which optimal balance of sensitivity and specificity can be obtained were derived according to Youden Index. Sensitivity (with optimal 95% confidence interval) is the probability that a test result will be positive when the disease is present (true positive rate-the probability that a patient will be accurately classified by the test). Specificity (with optimal 95% confidence interval) is probability that a test result will be negative when the disease is not present (true negative rate-the probability that a nonpatient will be accurately classified 
| RESULTS
| MMSE scores in patients with MCI and AD
The MMSE scores of HS women and men were 28.0 ± 1.9, 29.1 ± 0.9, respectively. Figure 1 shows that MMSE scores were decreased in MCI and AD. A significant difference for the main effect, between groups, was detected for MMSE (F(4,225) = 722.076; p = .000). There was no difference in the MMSE values between women (26.0 ± 2.4) and men (26.0 ± 1.8) with MCI. The MMSE scores were decreased in mild AD (women 23.9 ± 2.0, men 23.2 ± 1.6), moderate AD (women 16.1 ± 2.5, men 17.5 ± 2.0), and severe AD (women 4.6 ± 4.1, men 4.5 ± 3.4). The decrease in MMSE scores in AD was more than that observed in MCI in both genders (p = .000 for moderate and severe AD vs. MCI) except in mild AD (women, p = .030; men, p = .002 vs.
MCI). In addition, significant differences (p = .000) were detected among the various stages of AD in women and men analyzed separately. However, no significant gender-dependent difference was detected for the same stage of AD between women and men when compared to each other.
| Serum 25(OH)D 3 concentrations in patients with MCI and AD
In HS, the mean serum concentrations of 25(OH)D 3 were 26.18 ± 7.18 ng/ml and 27.42 ± 8.05 ng/ml in women and men participants, respectively. A significant (F(4,225) = 25.869, p = .000) main effect of 25(OH)D 3 was obtained in MCI and AD. 
| Serum 1,25(OH) 2 D 3 concentrations in patients with MCI and AD
In HS, the mean serum concentrations of 1,25(OH) 2 D 3 were 53.05 ± 13.04 pg/ml and 54.12 ± 14.34 pg/ml in women and men participants, respectively. Figure 3a shows that, in women, the concentrations of 1,25(OH) 2 D 3 were 55.38 ± 22.85 pg/ml (MCI), 62.53 ± 17.03 pg/ml (mild AD), 54.22 ± 13.71 pg/ml (moderate AD), and 61.84 ± 26.45 pg/ml (severe AD). Moreover, Figure 3b shows that, in men, the concentrations of 1,25(OH) 2 D 3 were 55.01 ± 18.00 pg/ml (MCI), 53.52 ± 19.20 pg/ml (mild AD), 57.02 ± 15.03 pg/ml (moderate AD), and 48.25 ± 9.55 pg/ml (severe AD). No significant difference among the groups was detected (F(4,225) = 0.583, p = .676).
| Correlations among MMSE, 25(OH)D 3, and 1,25(OH) 2 D 3
Table 1 and Figure 4 show that no correlation was evident in HS.
On the other hand, in MCI, the largest and significant correlation (Table 2) . The cutoff value of 25(OH)D 3 was higher than MMSE, especially in patients with AD whether evaluated against HS or other groups of AD. Moreover, higher (10 times) LR+ than LR− was observed for The correlation coefficient magnitude (r) is determined according to Pearson's correlation: small (r = .1), medium (r = .3), and large (r = >.5). * Significant correlation.
| Receiver operating characteristic (ROC) analysis
25(OH)D3 (data not shown). T A B L E 1 Correlations among MMSE, 25 (OH)D3 and. 1,25(OH)2 D3 in healthy subjects (HS) and patients with mild cognitive impairment (MCI) and Alzheimer's diseases (AD)
| Univariate and multivariate logistic regression analyses
The prediction values were evaluated for each of MCI and AD groups against HS. Univariate analysis of each predictor alone (Table 4) shows that significant (p = .0001) prediction by age (β = +0.133; Wald = 12.12; OR = 1.143; CC = 71%; p = .0001) and gender (β = −0.944; Wald = 4.49; OR = 0.389; CC = 64%; p = .034) was obtained in moderate AD. These results indicate that for each one unit increase of age (1 year), the odds of disease risk increases by 1.143 (53% probability). In case of gender, women were considered as the reference. In other words, the negative value of β indicates that women have 2.6 (1/0.389 = 2.6) times the risk of the disease than men. Moreover, it can also be seen from Table 4 
| DISCUSSION
The present results show that MMSE and 25(OH)D 3 (but not 1,25(OH) 2 D 3 ) were decreased in MCI and various stages of AD.
Although MMSE is one of the most widely used tools in the evaluation of cognitive status, there is still a debate about its diagnostic accuracy.
Some studies have reported that MMSE lacks diagnostic specificity and has limited diagnostic accuracy, particularly for distinguishing between normal cognition and MCI, and MCI from demential patients with AD (Chapman et al., 2016) and in measuring the progression of Alzheimer's disease (Clark et al., 1999) . On the other hand, MMSE has been regarded as a good first step in the evaluation of cognitive status and effectively separating those with mild AD from normal aging and MCI (Benson, Slavin, Tran, Petrella, & Doraiswamy, 2005) . : squared multiple correlation coefficient; SE: standard errors of the regression coefficients; Sig: two-sided observed significance levels (p) for the t statistics. CI: confidence interval; *Significant p values. The predictors 25(OH)D3, 1,25(OH)2D3 and gender (independent variable) were used to predict MMSE (dependent variable). et al., 1975) . MMSE had also been reported to predict converters to AD (Devanand et al., 2008; Palmqvist et al., 2012) . The present study highlights the value of MMSE and 25(OH)D 3 in the differential diagnosis and prediction of MCI, mild AD, moderate AD, and severe AD at a sensitivity rate >80. The differences among the results reported for MMSE could be attributed to the analyses approach such as selection of the cutoff values, and the patients' cultural, education, and demographic specificities. It is also noteworthy to mention that MMSE could be influenced by changes that could accompany dementia. A low level of the MMSE score is associated with low plasma phosphate (Haglin & Backman, 2016) . (Jones, Strugnell, & DeLuca, 1998) . 1,25(OH) 2 D 3 inhibits its own synthesis and that of its precursor 25(OH)D 3 (Bell, Shaw, & Turner, 1984) . It has been reported that 1,25(OH) 2 D 3 kinetics do not change by aging in healthy men and women (Eastell et al., 1991; Halloran, Portale, Lonergan, & Morris, 1990) . The production of 1,25(OH)2D3 could take place extrarenally and regulated endocrinologically. It has been reported that 1,25(OH) 2 D 3 is increased by parathyroid hormone (Eastell et al., 1991) and cytokines, including TNF (Bikle & Vitamin, 2014) .
However, serum 25(OH)D3 is negatively correlated with TNFα, IL-1β or IL-6 levels in healthy subjects and patients with MCI, but positively with late-onset AD (Dursun et al., 2016) . As TNF is increased in AD (Gezen-Ak et al., 2013) , it is possible that the increased TNFα cerebral blood flow (Farid et al., 2012) , brain volume and gray matter thickness (Brouwer-Brolsma et al., 2015; Buell et al., 2010; Hooshmand, Lökk, & Solomon, 2014) and clearance of aggregated Aβ in the AD brain (Durk et al., 2014; Masoumi, Goldenson, & Ghirmai, 2009; Yu et al., 2011) . On the other hand, low serum 25(OH)D 3 is associated with neuronal damages (Gezen-AK, Yilmazer, & Dursun, 2014) , MCI (Annweiler et al., 2012) , multidomain MCI (Yin et al., 2015) and AD (Annweiler et al., 2015; Balion, Griffith, & Strifler, 2012; Chei et al., 2014; Littlejohns, Henley, & Lang, 2014) . The present results showed that 25(OH)D 3 is involved in the decrease of MMSE, and predict MCI, mild AD, and moderate AD. It was the only significant predictor of severe AD. It differentiated the disease from HS at a sensitivity >90%, but exhibited only a poor-weak diagnostic power when the evaluation was carried out among the stages of AD. It should be noted that although 25(OH)D 3 was decreased in MCI and AD, no difference was observed between women and men but it predicted a 2.5 times higher incidence of AD in women than in men. This result is in line with that reported 1.5-3 times higher incidence of AD in women than the incidence in men (Baum, 2005 
